These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 765146)

  • 61. Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.
    Das Gupta V; Gibbs CW; Ghanekar AG
    Am J Hosp Pharm; 1978 Nov; 35(11):1382-5. PubMed ID: 568384
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

  • 63. [Studies on the mixing of eutectic forming drugs. 2].
    Kata M; Wayer M
    Pharmazie; 1975 Aug; 30(8):533-5. PubMed ID: 170633
    [No Abstract]   [Full Text] [Related]  

  • 64. [Some aspects of drug-pharmaceutic aid interactions and their effects].
    Keipert S
    Pharmazie; 1984 Sep; 39(9):644-7. PubMed ID: 6505003
    [No Abstract]   [Full Text] [Related]  

  • 65. Dry coating, a novel coating technology for solid pharmaceutical dosage forms.
    Luo Y; Zhu J; Ma Y; Zhang H
    Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [New formulations to be used in dental pharmacology].
    Korbar-Smid J; Sumer-Toldi D
    Zobozdrav Vestn; 1980; 35(5-6):179-83. PubMed ID: 6943878
    [No Abstract]   [Full Text] [Related]  

  • 67. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
    Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
    J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [New thickening agents in the formulation of suspensions, emulsions and gels].
    Moës A
    Farmaco Prat; 1972 Mar; 27(3):119-46. PubMed ID: 5022793
    [No Abstract]   [Full Text] [Related]  

  • 69. [Aerosil and its use in pharmaceutical practice].
    Aliushin MT; Astrakhanova MM
    Farmatsiia; 1968; 17(6):73-7. PubMed ID: 4305706
    [No Abstract]   [Full Text] [Related]  

  • 70. [Liposomes and the possibilities of using them in pharmacy and pharmacology].
    Tentsova AI; Kovaleva NS; Iarova EA; Ivkov NN
    Farmatsiia; 1976; 25(3):82-5. PubMed ID: 780135
    [No Abstract]   [Full Text] [Related]  

  • 71. Basics of sterile compounding: unique and special characteristics of sterile dosage forms.
    Akers MJ
    Int J Pharm Compd; 2014; 18(6):479-84. PubMed ID: 25906625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microencapsulation.
    Luzzi LA
    J Pharm Sci; 1970 Oct; 59(10):1367-76. PubMed ID: 4919443
    [No Abstract]   [Full Text] [Related]  

  • 73. [Studies on the mixing of eutectic forming drugs].
    Kata M; Wayer M
    Pharmazie; 1975 Jun; 30(6):382-5. PubMed ID: 169528
    [No Abstract]   [Full Text] [Related]  

  • 74. [Formulation of pharmaceutical suspensions].
    Arancibia A
    Farmaco Prat; 1971 Dec; 26(12):721-52. PubMed ID: 5142766
    [No Abstract]   [Full Text] [Related]  

  • 75. Basics of compounding: Tips and hints, part 2: compounding with solutions, suspensions, emulsions, and lotions.
    Allen LV
    Int J Pharm Compd; 2014; 18(2):137-8. PubMed ID: 24881118
    [No Abstract]   [Full Text] [Related]  

  • 76. [Unithiol as a stabilizer of injection solutions of ascorbic acid].
    Gladkikh SP; Belozerova OP; Mikhaĭlova GS; Karmanova VA
    Farmatsiia; 1974; 23(5):65-7. PubMed ID: 4464150
    [No Abstract]   [Full Text] [Related]  

  • 77. [Extraction photometric determination of pharmaceutical preparations in the form of eosinates].
    Benzar TP
    Farm Zh; 1971; 26(2):42-6. PubMed ID: 4114892
    [No Abstract]   [Full Text] [Related]  

  • 78. Hydrolysis in pharmaceutical formulations.
    Waterman KC; Adami RC; Alsante KM; Antipas AS; Arenson DR; Carrier R; Hong J; Landis MS; Lombardo F; Shah JC; Shalaev E; Smith SW; Wang H
    Pharm Dev Technol; 2002 May; 7(2):113-46. PubMed ID: 12066569
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dry blending process scale-up for a very low dose drug candidate.
    Wu LS; Pang J; Chen JG; Hussain MA
    AAPS PharmSciTech; 2000 Aug; 1(3):E-TN2. PubMed ID: 14727902
    [No Abstract]   [Full Text] [Related]  

  • 80. [Polyols-pharmaceutical and toxicological characteristics. I].
    Dominguez-Gil A; Cadorniga R
    Farmaco Prat; 1971 Jul; 26(7):394-404. PubMed ID: 5561804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.